Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway
Journal of Atherosclerosis and Thrombosis · 01.02.2023 · 30 (2) · 138-149
DOI: 10.5551/jat.63460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.02.2023. Verfasst von Li-Wei Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Forensic Medicine, Xinxiang Medical University. Hauptthemen laut MEDLINE: NF-kappa B, Coronary Artery Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AIM: Roles of fibroblast growth factor 23 (FGF23) in endothelial dysfunction remain controversial, and evidence from population-based studies is lacking. The present study aimed to explore the effects of FGF23 on endothelial dysfunction on the basis of both clinical data of patients with coronary artery disease (CAD) and the in vitro research in human umbilical vein endothelial cells (HUVECs). METHODS: A total of 321 CAD patients were enrolled after coronary angiography, brachial artery flow-mediated dilation (FMD) was assessed using ultrasound equipment. Serum FGF23, nitric oxide (NO), and endothelin-1 (ET-1) were detected via enzyme-linked immunosorbent assay. Apoptosis was determined using the annexin V-fluorescein isothiocyanate/propidium lodide apoptosis detection kit. Cell migration was evaluated by wound healing and transwell migration assays. Reactive oxide species levels were determined using fluorescent probes, and NF-κB p65 nuclear translocation was assessed via immunofluorescence. RESULTS: Serum FGF23 was significantly increased in CAD patients combined with severe endothelial dysfunction (FMD <2%) compared to those with FMD ≥ 2% (P<0.001). Furthermore, the levels of FGF23 were negatively correlated with NO, whereas positively correlated with ET-1 both in unadjusted analysis and multivariate-adjusted analysis. In HUVECs, FGF23 interfered with the bioavailability of NO via increased oxidative stress. Moreover, FGF23 directly impaired the endothelium by promoting HUVECs apoptosis and attenuating the migration of HUVECs. Additional experiments showed that FGF23 induced endothelial injury through activation of the NF-κB signaling pathway. CONCLUSIONS: Elevated FGF23 is clinically associated with endothelial dysfunction in CAD patients, and FGF23 impairs endothelial function through activation of the NF-κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Forensic Medicine, Xinxiang Medical University.
- Xinxiang Key Laboratory of Metabolism and Integrative Physiology.
- The Third Affiliated Hospital of Xinxiang Medical University.
Zitieren
APA
Guo, L. W., Wang, Y. K., Li, S. J., Yin, G. T., & Li, D. (2023). Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway. Journal of Atherosclerosis and Thrombosis, 30(2), 138-149. https://doi.org/10.5551/jat.63460
Vancouver
Guo LW, Wang YK, Li SJ, Yin GT, Li D. Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway. Journal of Atherosclerosis and Thrombosis. 2023;30(2):138-149. doi:10.5551/jat.63460
BibTeX
@article{Guo2023,
author = {Guo, Li-Wei and Wang, Yi-Kai and Li, Shi-Jie and Yin, Guo-Tian and Li, Duan},
title = {Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2023},
volume = {30},
number = {2},
pages = {138--149},
doi = {10.5551/jat.63460}
}
EUVIMED